Skip to main content
. 2019 Sep 12;11(9):2193. doi: 10.3390/nu11092193

Table 1.

Baseline characteristics of the young adults (n = 52) and elderly (n = 48) study populations.

Young Adult (n = 52) Elderly (n = 48) All Young Adults vs. All Elderly
Placebo (n = 27) Pectin (n = 25) p-Value Placebo (n = 24) Pectin (n = 24) p-Value p-Value
Age (years) 22.8 ± 4.1 23.4 ± 4.5 0.614 69.8 ± 2.4 69.5 ± 3.2 0.723 <0.001
Female (%) 48.2 68.0 0.148 50.0 37.5 0.383 0.164
BMI (kg/m2) 22.6 ± 2.7 23.2 ± 2.7 0.444 26.2 ± 2.8 25.5 ± 2.6 0.334 <0.001
Medication (%) 0 0 1.000 33.3 45.8 0.376 <0.001
PPI (%) 0 0 1.000 12.5 12.5 1.000 <0.001
Statins (%) 0 0 1.000 4.2 4.2 1.000 <0.001
Antihypertensives (%) 0 0 1.000 8.3 12.5 0.637 <0.001
Other medication (%) 0 0 1.000 12.5 16.7 0.683 <0.001

Differences in age and BMI between all young adults and elderly, or between placebo group and pectin group, were tested using T-tests. Differences in sex (i.e., female or male) were tested with chi-square tests. Differences in medication use were tested by Fisher’s exact tests. Values are presented as mean ± SD or percentage (%). BMI, body mass index. PPI, proton-pump inhibitors.